Renal tubular epithelial cell protection (RTEC or TEC)

Renal tubular epithelial cells (RTECs or TECs) are a major epithelial cell population in the kidney responsible for reabsorbing solutes and water, with high metabolic demands and susceptibility to injury due to hypoxia and toxic exposures. Protective strategies aimed at these cells focus on preserving their structure and function during and after acute kidney injury or chronic insult. Protection of RTECs is increasingly referred to in the context of interventions that promote adaptive repair, prevent maladaptive repair and fibrosis, inhibit senescence, or modulate immune interactions. While not a single molecular target, RTEC protection is a therapeutic area of interest. Molecular approaches (such as RXRα activation by bexarotene), anti-apoptotic strategies, and immune cell modulation are employed to preserve RTEC viability and function, highlighting the centrality of these cells in kidney disease pathogenesis and therapy. In summary: "Renal tubular epithelial cell protection" is not a single, canonical molecular or receptor target, but denotes a cell-protective biological process or therapeutic approach. For drug discovery and mechanistic studies, one must specify the actionable target (such as RXRα, CCR2, key pathways, or proteins in RTECs) rather than the cell type itself.

Other names

Tubular epithelial cellrenal epithelial cellRTECTEC

Promotion of adaptive repair and regeneration of TECs; Inhibition of apoptosis; Modulation of epigenetic regulators and transcription factors to restore protective cellular states; Immune cell clearance of damaged or senescent TECs